Related references
Note: Only part of the references are listed.Bottom-Up Engineering of Well-Defined 3D Microtissues Using Microplatforms and Biomedical Applications
Geon Hui Lee et al.
ADVANCED HEALTHCARE MATERIALS (2016)
The hypoxic microenvironment: A determinant of cancer stem cell evolution
Amancio Carnero et al.
BIOESSAYS (2016)
Positive feedback loop between cancer stem cells and angiogenesis in hepatocellular carcinoma
Hong Yao et al.
CANCER LETTERS (2016)
Liquid-based three-dimensional tumor models for cancer research and drug discovery
Stephanie L. Ham et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2016)
Hypoxia regulates stemness of breast cancer MDA-MB-231 cells
Jing Xie et al.
MEDICAL ONCOLOGY (2016)
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA
Chuanzhao Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Self-renewal of CD133hi cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer
Pasquale Sansone et al.
NATURE COMMUNICATIONS (2016)
Anti-miR delivery strategies to bypass the blood-brain barrier in glioblastoma therapy
Dong Geon Kim et al.
ONCOTARGET (2016)
Mathematical modelling of phenotypic plasticity and conversion to a stem-cell state under hypoxia
Andrew Dhawan et al.
SCIENTIFIC REPORTS (2016)
Interfacial Tension Effect on Cell Partition in Aqueous Two-Phase Systems
Ehsan Atefi et al.
ACS APPLIED MATERIALS & INTERFACES (2015)
Enhancement of hypoxia-activated prodrug TH-302 anti-tumor activity by Chk1 inhibition
Fanying Meng et al.
BMC CANCER (2015)
Efficacy and safety of the hypoxia-activated prodrug TH-302 in combination with gemcitabine and nab-paclitaxel in human tumor xenograft models of pancreatic cancer
Jessica D. Sun et al.
CANCER BIOLOGY & THERAPY (2015)
TH-302 in Combination with Radiotherapy Enhances the Therapeutic Outcome and Is Associated with Pretreatment [18F]HX4 Hypoxia PET Imaging
Sarah G. J. A. Peeters et al.
CLINICAL CANCER RESEARCH (2015)
Phytochemicals potently inhibit migration of metastatic breast cancer cells
Stephanie Lemmo Ham et al.
INTEGRATIVE BIOLOGY (2015)
The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast CD44/CD24 expression in breast cancer
Nilgun Kapucuoglu et al.
PATHOLOGY RESEARCH AND PRACTICE (2015)
Chemotherapy triggers HIF-1-dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
Haiquan Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Effect of Shape, Size, and Aspect Ratio on Nanoparticle Penetration and Distribution inside Solid Tissues Using 3D Spheroid Models
Rachit Agarwal et al.
ADVANCED HEALTHCARE MATERIALS (2015)
Three-dimensional in vitro tumor models for cancer research and drug evaluation
Xian Xu et al.
BIOTECHNOLOGY ADVANCES (2014)
Aqueous biphasic cancer cell migration assay enables robust, high- throughput screening of anti- cancer compounds
Stephanie Lemmo et al.
BIOTECHNOLOGY JOURNAL (2014)
Carbonic anhydrase 9 is associated with chemosensitivity and prognosis in breast cancer patients treated with taxane and anthracycline
Naoki Aomatsu et al.
BMC CANCER (2014)
HER2, MET and FGFR2 oncogenic driver alterations define distinct molecular segments for targeted therapies in gastric carcinoma
Y. J. Liu et al.
BRITISH JOURNAL OF CANCER (2014)
Enriched CD44+/CD24- population drives the aggressive phenotypes presented in triple-negative breast cancer (TNBC)
Fei Ma et al.
CANCER LETTERS (2014)
Optimization of Aqueous Biphasic Tumor Spheroid Microtechnology for Anti-cancer Drug Testing in 3D Culture
Stephanie Lemmo et al.
CELLULAR AND MOLECULAR BIOENGINEERING (2014)
Sox2 promotes tamoxifen resistance in breast cancer cells
Marco Piva et al.
EMBO MOLECULAR MEDICINE (2014)
Strong correlation between N-cadherin and CD133 in breast cancer: role of both markers in metastatic events
Carolin Bock et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
Phase II Study of the Safety and Antitumor Activity of the Hypoxia-Activated Prodrug TH-302 in Combination With Doxorubicin in Patients With Advanced Soft Tissue Sarcoma
Sant P. Chawla et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer
Danfang Zhang et al.
MOLECULAR CANCER (2014)
Dual Targeting of Hypoxia and Homologous Recombination Repair Dysfunction in Triple-Negative Breast Cancer
Francis W. Hunter et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Ultralow Interfacial Tensions of Aqueous Two-Phase Systems Measured Using Drop Shape
Ehsan Atefi et al.
LANGMUIR (2014)
Tackling the cancer stem cells - what challenges do they pose?
Diwakar R. Pattabiraman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Hypoxia promotes stem cell-like phenotype in multiple myeloma cells
B. Muz et al.
BLOOD CANCER JOURNAL (2014)
Extracellular matrix components in breast cancer progression and metastasis
Thordur Oskarsson
BREAST (2013)
New strategies for targeting the hypoxic tumour microenvironment in breast cancer
Carol Ward et al.
CANCER TREATMENT REVIEWS (2013)
Relapsed Triple-Negative Breast Cancer: Challenges and Treatment Strategies
Valentina Guarneri et al.
DRUGS (2013)
Cell to extracellular matrix interactions and their reciprocal nature in cancer
Marianne van Dijk et al.
EXPERIMENTAL CELL RESEARCH (2013)
CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer
Suresh Kumar Swaminathan et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Cancer stem cells: The challenges ahead
Jan Paul Medema
NATURE CELL BIOLOGY (2013)
Three-Dimensional-Engineered Matrix to Study Cancer Stem Cells and Tumorsphere Formation: Effect of Matrix Modulus
Xiaoming Yang et al.
TISSUE ENGINEERING PART A (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
A CD44-/CD24+ phenotype is a poor prognostic marker in early invasive breast cancer
Mohamed A. H. Ahmed et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
CD24 Is an Effector of HIF-1-Driven Primary Tumor Growth and Metastasis
Shibu Thomas et al.
CANCER RESEARCH (2012)
Hypoxia-Inducible Factors in Physiology and Medicine
Gregg L. Semenza
CELL (2012)
CDK4/6 inhibition antagonizes the cytotoxic response to anthracycline therapy
A. Kathleen McClendon et al.
CELL CYCLE (2012)
CD44+/CD24- phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma
Yan Lin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
Molecular and Cellular Pharmacology of the Hypoxia-Activated Prodrug TH-302
Fanying Meng et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Cancer stem cells and drug resistance: the potential of nanomedicine
Serguei Vinogradov et al.
NANOMEDICINE (2012)
Sox2 expression in breast tumours and activation in breast cancer stem cells
O. Leis et al.
ONCOGENE (2012)
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
Gregg L. Semenza
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Radiological features of triple-negative breast cancers (73 cases)
M. Boisserie-Lacroix et al.
Diagnostic and Interventional Imaging (2012)
HIF Induces Human Embryonic Stem Cell Markers in Cancer Cells
Julie Mathieu et al.
CANCER RESEARCH (2011)
Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
Nadine Rohwer et al.
DRUG RESISTANCE UPDATES (2011)
The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24- stem cell-like breast cancer cells in human tumors
Lauren L. C. Marotta et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Clinicopathologic correlation of cancer stem cell markers CD44, CD24, VEGF and HIF-1 alpha in ductal carcinoma in situ and invasive ductal carcinoma of breast: An immunohistochemistry-based pilot study
Zhen Wang et al.
PATHOLOGY RESEARCH AND PRACTICE (2011)
Differential Impact of EGFR-Targeted Therapies on Hypoxia Responses: Implications for Treatment Sensitivity in Triple-Negative Metastatic Breast Cancer
Abderrahim El Guerrab et al.
PLOS ONE (2011)
Targeting hypoxia in cancer therapy
William R. Wilson et al.
NATURE REVIEWS CANCER (2011)
Polymeric Aqueous Biphasic Systems for Non-Contact Cell Printing on Cells: Engineering Heterocellular Embryonic Stem Cell Niches
Hossein Tavana et al.
ADVANCED MATERIALS (2010)
Hypoxia inducible factors in cancer stem cells
J. M. Heddleston et al.
BRITISH JOURNAL OF CANCER (2010)
Complex Display of Putative Tumor Stem Cell Markers in the NCI60 Tumor Cell Line Panel
Christina H. Stuelten et al.
STEM CELLS (2010)
Cardiomyocyte death in doxorubicin-induced cardiotoxicity
Yi-Wei Zhang et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2009)
The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy
E. Y. Tan et al.
BRITISH JOURNAL OF CANCER (2009)
Nanolitre liquid patterning in aqueous environments for spatially defined reagent delivery to mammalian cells
H. Tavana et al.
NATURE MATERIALS (2009)
The clinicopathologic and prognostic significance of CD44+/CD24-/low and CD44-/CD24+ tumor cells in invasive breast carcinomas
Eleni Mylona et al.
HUMAN PATHOLOGY (2008)
Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity
Richard Sullivan et al.
MOLECULAR CANCER THERAPEUTICS (2008)
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors
Ittai Ben-Porath et al.
NATURE GENETICS (2008)
Drug resistance and the solid tumor microenvironment
Olivier Tredan et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
The third dimension bridges the gap between cell culture and live tissue
Francesco Pampaloni et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Hypoxia-inducible factors, stem cells, and cancer
Brian Keith et al.
CELL (2007)
Drug penetration in solid tumours
Andrew I. Minchinton et al.
NATURE REVIEWS CANCER (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Hypoxia-mediated down-regulation of bid and bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance
JT Erler et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Exploiting tumour hypoxia in cancer treatment
JM Brown et al.
NATURE REVIEWS CANCER (2004)
Fibronectin and laminin increase resistance to ionizing radiation and the cytotoxic drug Ukrain® in human tumour and normal cells in vitro
N Cordes et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2003)
Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies
AM Shannon et al.
CANCER TREATMENT REVIEWS (2003)
Hypoxia attenuates the p53 response to cellular damage
M Achison et al.
ONCOGENE (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Hypoxia-inducible factor 1 alpha is essential for cell cycle arrest during hypoxia
N Goda et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
The hypoxic tumour microenvironment and metastatic progression
P Subarsky et al.
CLINICAL & EXPERIMENTAL METASTASIS (2003)
Share Paper
